CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Adjusts Price Target on Regeneron Pharmaceuticals to $779 From $758

Neutral
AI Analysis

Summary

Morgan Stanley increased its price target on Regeneron Pharmaceuticals from $758 to $779, a modest upward adjustment.

Importance:2/10
Sentiment:
0.20
price_targetanalyst_upgrade
Related Companies

Read the original article

Published by yahoo_finance on October 7, 2026 12:58 PM

Read Original